LAYNA YIP TELLEZ: Open Payments
NPI 1174192157 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,945 in 90 payments from 16 companies in 2025. Trend: 2023 $1,618 · 2024 $2,300 · 2025 $1,945
Food & beverage: $1,779Education: $166
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $432 |
| ABBVIE INC. | 13 | $312 |
| Madrigal Pharmaceuticals | 11 | $213 |
| QOL Medical, LLC | 10 | $188 |
| Ardelyx, Inc. | 10 | $187 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $169 |
| Lilly USA, LLC | 5 | $98 |
| Celltrion USA Inc. | 3 | $77 |
| Aimmune Therapeutics, Inc. | 4 | $64 |
| PFIZER INC. | 2 | $52 |
Products named: TREMFYA, REZDIFFRA, Sucraid, IBSRELA, SKYRIZI, ENTYVIO, OMVOH, RINVOQ.
Industry payments across FL — which companies pay providers there.
